CLINICAL_TRIALS
trial_result
· 2021-08-05
Clinical Trial Update: Eltrombopag in Elderly Acute Myelogenous Leukemia (AML) [Phase 1, Phase 2]
Summary
Phase 1/2 trial of eltrombopag in elderly patients with acute myeloid leukemia has been terminated; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Acute Myelogenous Leukemia (AML) | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-08-05